Efficacy and safety of selenium as an add-on therapy to selective serotonin reuptake inhibitors in patients with obsessive compulsive disorder – a prospective randomised open-label study

Background: Obsessive–compulsive disorder (OCD) often shows an incomplete response to selective serotonin reuptake inhibitors (SSRIs). Selenium, an antioxidant micronutrient, may improve treatment outcomes when used as an adjunct. Aims and Objectives: This study aims to evaluate the safety and ef...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Sivagami R, Gautham M, Firoze M
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Manipal College of Medical Sciences, Pokhara 2026-06-01
Ráidu:	Asian Journal of Medical Sciences
Fáttát:	obsessive-compulsive disorder; selenium; selective serotonin reuptake inhibitors; yale-brown obsessive compulsive scale; adjunctive therapy
Liŋkkat:	https://ajmsjournal.info/index.php/AJMS/article/view/5251
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!